MarketPulse

cancer detection

3 articles
The Motley FoolThe Motley Fool··Lee Samaha

Grail Stock Surges on Analyst Optimism Despite Cancer Test Setback

Grail stock jumped 11.4% as Wall Street analysts see upside in its cancer detection test despite February trial disappointment.
GRALFDA approvalcancer detection
BenzingaBenzinga··Vandana Singh

Nvidia GPU Tech Cuts Cancer Detection Time to Hours, Partners With Droplet Biosciences

Nvidia and Droplet Biosciences partnership cuts cancer detection to 24 hours post-surgery using GPU-accelerated genomics, reducing computational time 92% and costs 30%.
NVDAcancer detectionGPU acceleration
BenzingaBenzinga··Vandana Singh

Caris Life Sciences Posts Surprise Profit as Cancer Detection Test Shows Clinical Superiority

Caris Life Sciences beat earnings expectations with 28-cent EPS and 125% revenue growth. Its cancer detection test showed clinical superiority, driving 20% stock gains.
CAIcancer detectionearly detection test